A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...

HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...

Rotavirus is the leading cause of death from diarrhea in children under five years old worldwide, claiming 200,000 lives annually 1. Current oral rotavirus vaccines are highly effective 2 in developed ...

Bharat Biotech International Limited has partnered with UNICEF and Gavi to slash the price of its malaria vaccine, Mosqivac, ...

Five-year exclusive distribution agreement builds foundation for niche vaccines and future collaboration in Malaysia -- ...

Hyderabad: Bharat Biotech International Ltd said Friday it has reached an equitable pricing agreement with Gavi, the Vaccine ...

Bharat Biotech cuts malaria vaccine price by ~40% to €5.50 per dose via Gavi-UNICEF pact backed by IFFIm funding.

In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...

Developing a vaccine: UNC’s Lineberger Cancer Center has received a $40 million grant to support vaccine development using AI ...

This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the biotech industry. Sign up here to get it delivered to your inbox.

Hyderabad-based Bharat Biotech has announced a 40% price reduction for its Mosqivac malaria vaccine, aiming to expand immunization access for children in high-burden regions starting in 2027.

Bharat Biotech’s Mosqivac malaria vaccine price cut by ~40% through Gavi-UNICEF deal, expanding access for up to 1 million ...